The Zacks Analyst Blog Highlights CRISPR Therapeutics, Editas Medicine, Sarepta Therapeutics and Beam Therapeutics
CRISPR Therapeutics, Editas Medicine, Sarepta Therapeutics and Beam Therapeutics are part of the Zacks top Analyst Blog....…
46,000€
4,07%
Echtzeit-Aktienkurs CRISPR Therapeutics AG
Bid:
Ask:
Nachrichten zur CRISPR Therapeutics AG Aktie
CRISPR Therapeutics to Present at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
ZUG, Switzerland and BOSTON, Oct. 05, 2022 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused…
CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $65.35, marking a +1.33% move from the previous day....…
Insiderhandel: Chief Executive Officer verkauft Aktien von Crispr Therapeutics im Wert von 1.615.160$
Kulkarni, Samarth - Vorstand - Tag der Transaktion: 2022-09-28...…